Guardant Health Inc reports results for the quarter ended June 30 - Earnings Summary

Guardant Health

30/07/2025 22:53

Guardant Health Inc GH.OQ reported a quarterly adjusted loss of 80 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -84 cents.  The mean expectation of twenty four analysts for the quarter was for a loss of 79 cents per share. Wall Street expected results to range from -92 cents to -54 cents per share.

Revenue rose 30.9% to $232.09 million from a year ago; analysts expected $211.22 million.

Guardant Health Inc's reported EPS for the quarter was a loss of 80 cents​.

The company reported a quarterly loss of $99.9 million.

Guardant Health Inc shares had fallen by 16.8% this quarter and gained 41.8% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 3.3% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 23 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Guardant Health Inc is $60.00, about 27.8% above its last closing price of $43.32

This summary was machine generated from LSEG data July 30 at 09:53 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
-0.79
-0.80
Missed
Mar. 31 2025
-0.81
-0.82
Missed
Dec. 31 2024
-0.74
-0.90
Missed
Sep. 30 2024
-0.74
-0.88
Missed